https://seekingalpha.com/news/3889548-study-suggests-covid-rebound-after-pfizers-paxlovid-likely-by-robust-not-weak-immune-response
A small study suggested that COVID-19 rebound may be likely due to a robust immune response rather than a weak one in patients who had taken Pfizer's (PFE) oral antiviral Paxlovid. The...
Create an account or login to join the discussion